AngeLab, a prenatal disease diagnosis project where Hahn-Schickard is involved, has been granted the Innovation Award as the best European H2020/7PM project at the European Nanoelectronics Forum 2016.
Within the EU-funded project AngeLab (A New GEnetic LABoratory for non-invasive prenatal diagnosis), Hahn-Schickard – together with 14 partners – develops a rapid test for the analysis of genetic diseases of unborn children. The project was established in 2012, with a budget of 11 million euro, focussing on the development of a line of systems based on lab-on-a-chip technology, capable of detecting foetus genetic conditions by analysing the mother’s blood. The project seeks to minimize current invasive techniques by developing diagnostic devices that are safer, more accessible and cheaper than current techniques for detecting genetic diseases before birth.
After the pilot production of the new devices, the systems are being technically validated with patients through more than 400 diagnostic tests carried out in centres of the Basque Health Service (Osakidetza).
Dr. Jesús M. Ruano López of the Spanish research institute IK4-Ikerlan (on the very left in the picture) accepted the price on behalf of the project team. He will coordinate the project until its end in March of 2017.